Who We Fund
Since 1949, LLS has provided more than $1.7 billion to the best and the brightest blood cancer researchers and biotech companies to support their groundbreaking research. Meet grantees and the companies who’ve joined our fight to find cures and help blood cancer patients everywhere.

Bruno Paiva
smoldering myeloma

Keisuke Ito
blood cancer stem cells and MDS metabolism

Robert Kridel
follicular lymphoma

Jason Butler
aging and leukemia

Thomas Kipps
Hairy Cell Leukemia

Jian Xu
leukemia and MPN biology

Larry Kwak
Mantle cell lymphoma, immunotherapy

Tanya Siddiqi
clinical trial access

Jaehyuk Choi
T-cell lymphoma

Brian Walker
smoldering myeloma, MGUS

Shannon Maude
Immunotherapy for ALL

Daniel Lucas
bone marrow and leukemia biology

Johann-Christoph Jann
AML/MDS

Frederick Locke
lymphoma and immunotherapy

Madhav Dhodapkar
multiple myeloma immunotherapy

Areej El-Jawahri
transplant survivorship

Julia Paczkowska
immunobiology of Hodgkin's disease

Carl June
CAR T immunotherapy

Lori Muffly
Equity in Access

Mark Hamilton
DLBCL and CAR-T

Amin Sobh
Myeloma biology

Zachary Epstein-Peterson
Peripheral T-cell lymphoma trial

Jeffrey Magee
pediatric AML

Alex Kentsis
pediatric leukemias

Luca Busino
DLBCL

Enterome
vaccine, FL, MZL

Zhijian Qian
blood cancer stem cells

Craig Jordan
AML

Inhye Ahn
CLL

Immunitas Therapeutics
immunotherapy, DLBCL, Hodgkin's

Katherine Borden
AML

William Matsui
Myeloma

Huda Salman
CMML

Christian Steidl
B-cell lymphomas

Matthew Frank
Lymphoma CART therapy

Britta Will
Leukemia and pre-leukemia

Meng Li
Equity in Access

Nizar Bahlis
Myeloma immunotherapy

Kerry Rogers
CLL

Eric Pietras
AML

Stacie Dusetzina
Equity in Access

Carisma Therapeutics
immunotherapy, CAR-macrophage

Jennifer Woyach
CLL trials

Dan Landau
cancer evolution biology

Kirk Schultz
pediatric transplantation

Jaroslaw Maciejewski
bone marrow failure

Robert Bradley
MDS

Jing Yang
Myeloma

Jianhua Yu
myeloma immunotherapy

Sergei Doulatov
Leukemias

Amit Verma
AML/MDS

Roland Walter
Antibody-based AML therapies

Michael Savona
MDS and leukemia

Michael Keller
COVID-19, immunotherapy

Robert Soiffer
transplantation

Susan Schwab
cancer immunology

Tak Mak
Immunotherapy

Steven Horwitz
T-cell lymphomas

Michael Green
lymphoma biology

Daniel Starczynowski
MDS and AML

Yan Liu
MDS

Christopher Booth
BPDCN

Arash Alizadeh
blood cancer biology and diagnosis

Zachary Hunter
Waldenström macroglobulinemia (WM)

Rajni Kumari
AML

Jonathon Cohen
lymphoma clinical trial access in Georgia

Stephen Nimer
myeloid cancer biology

Constellation Pharmaceuticals
myeloproliferative neoplasms

David Ritchie
Hairy Cell Leukemia

Daisuke Nakada
preleukemia, leukemia

Lindsey Montefiori
pediatric leukemia

Ryvu Therapeutics
AML, MDS

Kymera Therapeutics
protein degraders, DLBCL, TCL, LGLL

Ravindra Majeti
preleukemia, AML

Maria "Ken" Figueroa
aging and leukemia

David Fruman
novel combinations

Courtney Jones
AML metabolism

Helen Parsons
Equity in Access

Kasey Leger
pediatric blood cancers

Ricky Johnstone
lymphoma and myeloma

Cailin Collins
Leukemia and pre-leukemia

Kathleen Sakamoto
pediatric AML

Adam de Smith
pediatric ALL and Down Syndrome

Jonas Jutzi
myeloproliferative neoplasms

Qingyu Luo
BPDCN

Catherine Smith
leukemia

Ronald Levy
immunotherapies, COVID-19

Timothy Ley
AML, precision medicine

Yusuke Isshiki
DLBCL and GCB Lymphomas

Logan Spector
childhood leukemia epidimiology

Lev Kats
myeloma and epigenetics

Eirini Papapetrou
blood cancer stem cells

Robert Signer
cancer stem cell biology

Lei Ding
myeloproliferative neoplasms, myelofibrosis

Pietro Genovese
transplant and AML

Michael Rout
follicular lymphoma, CAR T

Lawrence Boise
CART and myeloma

Armin Rashidi
gut bacteria and transplant success

Grant Challen
preleukemia, leukemia

Jennifer Trowbridge
aging and leukemia

Charles Mullighan
pediatric ALL

Sarah Tasian
pediatric leukemias

Timothy Graubert
AML and MDS biology

Tomasz Skorski
myeloproliferative neoplasms, AML

Nicolas Nassar
pediatric leukemia

Patrizia Mondello
IgM MGUS & Waldenstrom Macroglobulinemia

Alexey Danilov
lymphoma

Marina Konopleva
MDS/AML metabolism

F. Lennie Wong
Equity in Access

Alison Moskowitz
lymphoma therapeutics

Rgenta Therapeutics
RNA-targeting, blood cancer

Daniel Thomas
Myelofibrosis

Noemí Puig Morón
Myeloma

Courtney DiNardo
clinical trials, AML

Mark Dawson
B-ALL and CAR-T resistance

Selina Chen-Kiang
Mantle cell lymphoma

Coleman Lindsley
AML/MDS

Mitchell Geer
leukemia biology

Sami Malek
blood cancer biology

Helen Heslop
Immunotherapy

Paolo Strati
Non-Hodgkin Lymphoma

Joachim Yahalom
Lymphoma

Lucy Godley
preleukemia

ImCheck Therapeutics
immunotherapy, AML

Carl Allen
pediatric blood cancers

Martin Dreyling
Mantle Cell Lymphoma

Jonathan Licht
DNA biology, myeloma

Matteo Bellone
Smoldering multiple myeloma

John Pimanda
AML, MDS

Michael Wang
Mantle Cell Lymphoma

Christiane Querfeld
T-cell lymphoma

Alec Zhang
myeloma, immunotherapy

Venkata Lokesh Battula
immunotherapy and AML

Liran Shlush
pre-leukemia

Kevin Shannon
pediatric AML

Clayton Smith
clinical trial access

Jane Oliaro
Myeloma & Lymphoma Immunotherapy

Justine Kahn
pediatric leukemia and lymphoma

Trent Hall
MDS

Robert Orlowski
(Smoldering) Multiple Myeloma

Adi Nagler
Bronchiolitis obliterans after transplant

Caroline Arber
myeloma CAR-T

Mendel Goldfinger
MDS/AML trials for the elderly

BioInvent International
immunotherapy, indolent NHL, CTCL

Kehan Ren
MDS

Caribou Biosciences
immunotherapy, allo-CAR, NHL, MM, AML

Alexandra Stevens
childhood AML

Oreofe Odejide
Equity in Access

George Vassiliou
pre-leukemia

Faron Pharmaceuticals
immunotherapy, MDS

Hong Wen
AML

John Crispino
MPNs, myelofibrosis

Adam Olszewski
Follicular and marginal zone lymphoma

Dane Vassiliadis
blood cancer biology

Kimberly Stegmaier
childhood blood cancers

Kirsten Williams
leukemia, immunotherapy

Caron Jacobson
lymphoma and immunotherapy

Nirav Shah
CAR-T for lymphoma

Kura Oncology
MLL leukemia, AML

Shannon McKinney-Freeman
transplant biology

Sahand Hormoz
MPN

Sylvain Simon
Immunotherapy, CAR-T safety

Abintus Bio
immunotherapy, in vivo CAR

Thomas LeBlanc
palliative care

Sam Butterworth
CMML

Christopher Flowers
clinical trial access

Simona Colla
Myeloma biology

Thorsten Zenz
Hairy cell leukemia

Sisi Chen
leukemia

Richard Lock
T-ALL

Neha Mehta-Shah
T-cell lymphoma

Eugenio Morelli
Myeloma

Alex Herrera
lymphoma and immunotherapy

Shan Lin
preleukemia, leukemia

Stephen Gottschalk
pediatric leukemia and CAR-T

Matthew Schwede
machine learning and AML

Ryan Wilcox
T-cell lymphoma

Andrew Lane
BPDCN

Vittoria Biotherapeutics
immunotherapy, CAR-T, TCL

Hao Jiang
leukemia biology

Peng Ji
myeloproliferative neoplasms

Suzanne Lentzsch
Myeloma

Thomas Koehnke
leukemia

Megan McNerney
AML/MDS

Rizwan Romee
Immunotherapy

Ari Melnick
epigenetics and lymphoma

Jayna Mistry
aging and leukemias

Steven Treon
Lymphomas and Waldenstrom's

Xu Ji
Equity in Access

Alfred Garfall
myeloma immunotherapy

Wendy Stock
T-cell ALL

Jessica Stewart
Epstein-barr virus and lymphomas

Wendy Béguelin
follicular lymphoma

Mala Shanmugam
myeloma

Ann-Kathrin Eisfeld
Racial diversity in AML

Qing Yi
Novel CAR-T

Daniel Herranz
T-ALL

Gareth Morgan
smoldering myeloma, MGUS

Jenny Wang
AML

Ryotaro Nakamura
ALL, CAR T

Eric Padron
CMML

Yiman Liu
Epigenetics and leukemia

Dan Vogl
myeloma, microenvironment

Yubin Zhou
peripheral T cell lymphoma

Christopher Reilly
leukemia

Rong Lu
preleukemia, leukemia

Aditi Shastri
AML, MDS

Baochun Zhang
immunotherapy

Jolanta Grembecka
leukemia therapeutics

Alieen Rowan
Adult T cell leukemia/lymphoma

Piers Patten
COVID-19

Ruben Carrasco
Myeloma

Margaret Shipp
lymphoma biology

Sean Post
diffuse large B-cell lymphoma

Caner Saygin
T-ALL

Ravi Bhatia
transplantation

Peter Klein
MDS

Tycel Phillips
Mantle Cell Lymphoma

Riccardo Dalla-Favera
lymphoma (DLBCL)

Affimed
immunotherapy, HL, PTCL

Suman Paul
T cell cancers and immunotherapy

Randall Davis
CLL

Saar Gill
AML immunotherapy

Omar Abdel-Wahab
Hairy cell leukemia

Markus Muschen
leukemia and lymphoma biology

Amer Zeidan
MDS and AML

Therese Vu
T-All and MLL

Lakshmi Nayak
brain tumors in lymphoma

Gaurav Goyal
Erdheim-Chester Disease

Roberta Zappasodi
lymphoma, immunotherapy

Nitin Jain
CLL

Brian Dalton
DNA mutations and myeloid cancers

Dren Bio
immunotherapy, LGLL

Liling Wan
AML

Catriona Jamieson
cancer stem cell biology

Frederike Kramer
MPNs

Juliette Bouyssou
leukemias and gender

Loren Walensky
pediatric leukemia

Yibin Yang
Lymphoma

Julia Maxson
AML

Dimericon Therapeutics
dimericons, blood cancer

Jalpa Doshi
Equity in Access

Michael Kharas
leukemia

Daniel Pollyea
AML

Todd Fehniger
NK/CART cell therapy for lymphomas and pediatric AML

Forty Seven
immunotherapy, AML

Jeremy Baeten
AML

Marc Seifert
Hairy cell leukemia

Elliot Stieglitz
CMML

Soheil Meshinchi
pediatric AML

Srividya Swaminathan
pediatric, immunotherapy

Reshmi Parameswaran
immunotherapy for hairy cell leukemia

Samuel Taylor
leukemia biology

Enrico Tiacci
Hairy cell leukemia

Takeshi Sugio
T-cell lymphoma

Catherine Bollard
pediatric blood cancers and immunotherapy

Immune-Onc Therapeutics
immunotherapy, AML, CMML

Grzegorz Nowakowski
Clinical trial access

Jennifer Lewis
URM Student

Taishi Yonezawa
AML

Stephen Oh
myeloproliferative neoplasms

Jianguo Tao
Mantle Cell Lymphoma

Anna Lee
AML

John Leonard
lymphoma research

Tyler Parsons
MPN and AML

Maximilian Stahl
AML immunotherapy

G. Greg Wang
DNA biology

Christopher Porter
Leukemia, lymphoma

Nathan Ungerleider
lymphoma biology

Marco Ruella
Immunotherapy for T-cell lymphoma

Sigurður Kristinsson
Smoldering myeloma

Christine Zhang
AML

Constantine Mitsiades
CAR-T and CAR-NK immunotherapies

Siddhartha Jaiswal
preleukemia

Gianpietro Dotti
CAR T and AML

Koichi Takahashi
AML/MDS

Sameer Parikh
COVID-19

Christian Marinaccio
MLL leukemias

Shirong Li
myeloma

Sattva Neelapu
DLBCL, CAR T

Jun Qi
Myeloma